Products
Platform
Research
Market
Learn
Bafna Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 12.46 | 10.96 | 12.16 | 7.15 | 8.80 |
| Other Income Qtr Cr | -0.67 | 0.03 | 0.59 | 0.30 | -0.03 |
| Operating Revenues Qtr | 13.13 | 10.93 | 11.57 | 6.85 | 8.84 |
Loading chart... | |||||
Operating Expenses Qtr | 8.89 | 10.70 | 11.94 | 9.72 | 8.65 |
Operating Profit Qtr | 4.24 | 0.22 | -0.38 | -2.87 | 0.18 |
EBITDA Qtr Cr | 2.73 | -21.46 | 0.22 | -2.56 | 0.15 |
Depreciation Qtr | 0.52 | 1.00 | 0.72 | 1.02 | 0.75 |
Net Profit Qtr | 0.32 | -22.33 | -0.59 | -2.13 | -1.28 |
Basic EPS Qtr | 0.20 | -94.39 | -0.25 | -0.90 | -0.80 |
Open Demat Account
Open Demat Account